SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-23-022693
Filing Date
2023-06-28
Accepted
2023-06-28 08:37:53
Documents
11

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 631117
2 ex4-1.htm EX-4.1 124311
3 ex4-2.htm EX-4.2 139531
4 ex5-1.htm EX-5.1 16001
5 ex5-2.htm EX-5.2 17987
6 ex10-14.htm EX-10.14 180780
7 ex10-15.htm EX-10.15 248001
8 ex23-1.htm EX-23.1 5075
9 ex5-2_001.jpg GRAPHIC 2950
10 ex5-1_001.jpg GRAPHIC 6373
11 ex5-1_002.jpg GRAPHIC 6373
  Complete submission text file 0001493152-23-022693.txt   1385734
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-272722 | Film No.: 231049417
SIC: 2834 Pharmaceutical Preparations